The client is participating in a Phase III clinical trial for a new antineoplastic agent. Which scientific rationale is the purpose of this phase of the pharmacology trials?
1. Determine optimum dosing, scheduling, and toxicity of the medication.
2. Determine effectiveness against specific tumor types.
3. Compare the new medication with the standard treatment procedures.
4. Further investigate to determine if the medication may have other uses.
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here